Hives (Urticaria): Common Triggers, When They Signal Something Serious, and How to Treat Them

Hives, medically termed urticaria, are raised, well-demarcated, intensely itchy wheals that appear on the skin, often with surrounding redness (flare), and characteristically resolve without leaving a mark within 24 hours — only to reappear elsewhere. They affect approximately 20 percent of people at some point during their lives, making them one of the most common dermatological presentations in both primary care and the emergency department. The majority of hive episodes are acute, self-limited, and caused by identifiable triggers. However, a meaningful subset of patients develops chronic urticaria that persists for months or years and significantly impairs quality of life. Understanding the difference between these two presentations, and recognizing the rare but dangerous complications of urticaria, is essential knowledge.

Acute vs Chronic Urticaria

Acute Urticaria

Acute urticaria is defined as hives lasting fewer than six weeks. The majority of cases are self-limiting and resolve with minimal treatment. In children, the most common cause is a viral infection — respiratory viruses, including rhinovirus, and enteroviruses are frequently culpable, and parents are often surprised to learn that hives can be a viral symptom rather than an allergic reaction to a medication or food. In adults, acute urticaria is more likely to be triggered by food, medication, or direct physical triggers. Approximately 50 percent of acute urticaria cases in adults have no identifiable cause after thorough evaluation.

Chronic Urticaria

Chronic urticaria is defined as hives occurring on most days for more than six weeks. It affects approximately 0.5 to 1 percent of the population at any given time and has a disproportionate impact on quality of life, with studies showing patients scoring their symptom burden similarly to patients with triple-vessel coronary artery disease in terms of daily impairment. Within chronic urticaria, two subtypes exist: chronic spontaneous urticaria (CSU), in which hives arise without an identifiable external trigger, and chronic inducible urticaria (CIndU), in which hives are reproducibly triggered by specific physical stimuli (pressure, cold, heat, vibration, sunlight, water, or exercise). Many patients have both. CSU is the more common and more challenging subtype to manage. Up to 50 percent of CSU cases have an underlying autoimmune mechanism — specifically, IgE or IgG autoantibodies against the high-affinity IgE receptor (FcεRI) on mast cells or against IgE itself, causing spontaneous mast cell degranulation.

Common Triggers

Foods

Food triggers are more commonly implicated in acute than chronic urticaria. The most frequently reported food triggers include shellfish, fish, peanuts, tree nuts, eggs, milk, wheat, and soy — though essentially any food can trigger urticaria in susceptible individuals. The reaction typically develops within minutes to two hours of ingestion. It is worth noting that food-induced urticaria is frequently suspected but far less often confirmed on formal allergy testing. A detailed food diary documenting the timing between eating and hive onset is more diagnostically useful than broad food allergy panels, which have high false-positive rates and tend to generate unnecessary dietary restrictions.

Medications

NSAIDs (ibuprofen, naproxen, aspirin) and antibiotics, particularly penicillins and sulfonamides, are the most common drug triggers for urticaria. NSAID-induced urticaria is often pharmacological rather than immunological — meaning it occurs through direct mast cell activation rather than IgE-mediated allergy — which is why multiple NSAIDs may cross-react. ACE inhibitors cause a distinct presentation called ACE inhibitor-induced angioedema, which involves swelling without hives and is mediated by bradykinin rather than histamine, making antihistamines ineffective for it.

Infections

Acute infections — particularly upper respiratory viral infections — are among the most common triggers of acute urticaria, especially in children. Bacterial infections, including streptococcal throat infections and urinary tract infections, can also trigger urticaria. In chronic urticaria, chronic infections such as Helicobacter pylori gastritis have been implicated and, in some patients, eradication of H. pylori leads to remission of urticaria.

Physical Triggers

Physical urticarias are triggered by specific physical stimuli. Dermographism (skin writing) — in which firm stroking of the skin produces a linear wheal — is the most common, affecting roughly 2 to 5 percent of the population. Cold urticaria triggers hives when the skin is exposed to cold temperatures or cold water; in severe cases, swimming in cold water can trigger systemic reactions. Pressure urticaria causes deep, delayed swelling several hours after sustained pressure. Solar urticaria develops within minutes of sun exposure. Exercise-induced urticaria (distinct from cholinergic urticaria, which is triggered by any rise in core body temperature) can occasionally trigger anaphylaxis, a particularly dangerous presentation.

Angioedema

Angioedema is deep tissue swelling involving the dermis and subcutaneous or submucosal tissue. It frequently accompanies urticaria (approximately 40 percent of urticaria patients develop angioedema at some point) but can also occur independently. Angioedema typically involves the lips, tongue, eyelids, hands, feet, and genitalia. When it involves the tongue, soft palate, or larynx, it constitutes a life-threatening emergency because swelling can obstruct the upper airway within minutes. Laryngeal angioedema presents with throat tightness, voice changes (hoarseness, muffled voice), stridor, and difficulty swallowing. Any patient with these symptoms requires immediate emergency evaluation — do not wait to see whether it improves spontaneously.

Hereditary angioedema (HAE), a rare genetic condition caused by C1 esterase inhibitor deficiency, produces recurrent angioedema without hives. It does not respond to antihistamines or epinephrine and requires specific treatments (C1 inhibitor concentrate, icatibant, or lanadelumab). If a patient has recurrent angioedema without accompanying urticaria, and antihistamines are ineffective, HAE must be considered.

Anaphylaxis Risk

Urticaria and angioedema can be the initial signs of systemic anaphylaxis. Anaphylaxis requires hives plus involvement of at least one additional organ system: respiratory (bronchospasm, wheezing), cardiovascular (hypotension, dizziness, loss of consciousness), gastrointestinal (severe cramping, vomiting), or neurological (confusion, loss of consciousness). Anaphylaxis is a medical emergency requiring immediate intramuscular epinephrine. The thigh is the preferred injection site. Antihistamines and corticosteroids are adjuncts — they are not first-line treatment for anaphylaxis and should never delay epinephrine administration.

Patients who have experienced anaphylaxis or severe allergic reactions to a known trigger should carry two epinephrine auto-injectors (EpiPens) at all times and receive detailed education on when and how to use them. A follow-up appointment with an allergist for formal testing, management planning, and evaluation for allergen immunotherapy is essential after any anaphylactic event.

Treatment: Acute Urticaria

H1 Antihistamines

Second-generation H1 antihistamines — cetirizine (Zyrtec), loratadine (Claritin), and fexofenadine (Allegra) — are the first-line treatment for urticaria. They are preferred over first-generation agents (diphenhydramine/Benadryl) because they are non-sedating, longer-acting, and safer for daily use. Current guidelines recommend starting at standard doses and up-dosing up to fourfold for inadequate response before adding other agents. Many dermatologists and allergists routinely use cetirizine 10 mg twice daily for more effective symptom control in acute flares.

H2 Antihistamines

H2 receptor antagonists (famotidine) target histamine receptors in the skin that H1 agents do not cover. While not effective as monotherapy, adding an H2 blocker to an H1 antihistamine can improve response in some patients, particularly for acute urticaria accompanying allergic reactions. The combination has a reasonable evidence base and is low-risk.

Short-Course Corticosteroids

A brief course of oral prednisone (typically 0.5 mg/kg/day for 5 to 7 days) can rapidly suppress acute urticaria flares unresponsive to antihistamines. Corticosteroids are not recommended for long-term management of chronic urticaria due to well-established risks of prolonged use (bone loss, metabolic effects, immunosuppression, adrenal suppression). They are a bridge, not a solution.

Treatment: Chronic Urticaria

The same antihistamine-first approach applies, with up-dosing as needed. For patients with CSU that is inadequately controlled on high-dose antihistamines — a situation that affects roughly 40 percent of patients with chronic urticaria — omalizumab (Xolair) is the recommended next step.

Omalizumab for Chronic Urticaria

Omalizumab is a biologic agent (anti-IgE monoclonal antibody) approved for chronic spontaneous urticaria in patients 12 and older. It binds free IgE in circulation, reducing the availability of IgE to activate mast cells and basophils. In clinical trials, 300 mg administered subcutaneously every four weeks achieved complete response (zero hives) in approximately 36 percent of patients and significantly reduced symptom burden in the majority. It is administered as an injection every four weeks and is generally very well tolerated. Cost and insurance access are practical barriers, though patient assistance programs exist. Omalizumab does not cure chronic urticaria, and symptoms may return after stopping treatment.

Autoimmune Urticaria

For the subset of patients with confirmed autoimmune CSU, cyclosporine A is sometimes used as a third-line agent when antihistamines and omalizumab fail or are inaccessible. It requires regular monitoring of blood pressure, renal function, and drug levels.

When to Carry Epinephrine

Epinephrine auto-injectors are indicated for patients who have experienced anaphylaxis, those with urticaria triggered by foods (especially peanuts, tree nuts, shellfish) or insect stings, and patients with exercise-induced anaphylaxis or cold urticaria severe enough to cause systemic reactions. The decision to prescribe epinephrine should be made by a physician and accompanied by patient education on its use.

Skin Biopsy

Skin biopsy is not routinely required for the diagnosis of typical urticaria. It is considered when urticarial vasculitis — a condition where hives persist beyond 24 hours, leave bruising, are painful rather than itchy, and may be associated with systemic disease — is suspected. Urticarial vasculitis shows leukocytoclastic vasculitis on biopsy and has different treatment implications. Biopsy is also helpful in distinguishing urticaria from urticarial bullous pemphigoid or other dermatological conditions that can mimic hives.

When to See a Doctor

Hives that fail to improve within a few days of antihistamine treatment, recur frequently, are accompanied by throat tightness or swelling, or persist beyond six weeks warrant physician evaluation. Chronic urticaria can be effectively managed with modern treatments including omalizumab, but it requires a proper diagnostic workup. JourneyDoctors connects you with trained specialists from $19. Start a consultation today — no waiting room, no referral needed.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment.

Frequently Asked Questions

How do I know if my hives are dangerous?

Hives alone — itchy welts that come and go — are not usually dangerous. Hives become a medical emergency when accompanied by throat tightness, difficulty swallowing, voice changes, wheezing, dizziness, drop in blood pressure, or loss of consciousness. These signs indicate anaphylaxis, which requires immediate intramuscular epinephrine and emergency care. When in doubt, call 911.

Can stress cause hives?

Yes. Stress triggers mast cell degranulation through neuropeptide release and can induce or exacerbate urticaria in susceptible individuals. Stress-related urticaria is typically cholinergic in pattern — small wheals distributed across the trunk triggered by elevated core body temperature, exercise, or emotional arousal. Stress management is a complementary component of managing chronic urticaria but is not a substitute for antihistamine therapy.

Should I take Benadryl for hives?

Diphenhydramine (Benadryl) works for hives but is not the preferred choice. It causes significant sedation, lasts only four to six hours, and has anticholinergic effects that are particularly problematic in older adults. Second-generation antihistamines — cetirizine, loratadine, or fexofenadine — are equally effective, non-sedating, and last 12 to 24 hours. Cetirizine is generally the most potent of the three for urticaria.

Why do my hives keep coming back every night?

Nocturnal urticaria is a common pattern and typically reflects the normal circadian variation in cortisol levels. Cortisol — which has anti-inflammatory effects — is at its lowest in the evening, allowing histamine-mediated reactions to peak at night. Taking a long-acting antihistamine like fexofenadine in the early afternoon, rather than at bedtime, can provide better overnight coverage. If hives reliably appear at the same time daily, this pattern is worth discussing with a dermatologist or allergist.

Can chronic urticaria be cured?

Most patients with chronic spontaneous urticaria experience natural remission within one to five years — approximately 50 percent achieve remission within one year, 80 percent within five years. During that time, effective symptom control with antihistamines and omalizumab is the goal. A minority of patients have chronic urticaria that persists for a decade or longer, requiring ongoing management rather than cure as the frame of reference.